Carillon Tower Advisers’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-723,248
Closed -$30.6M 470
2019
Q4
$30.6M Buy
723,248
+34,200
+5% +$1.45M 0.2% 175
2019
Q3
$28.8M Sell
689,048
-2,025
-0.3% -$78.9K 0.2% 172
2019
Q2
$25.4M Sell
691,073
-145,400
-17% -$5.3M 0.17% 213
2019
Q1
$31.9M Sell
836,473
-310,175
-27% -$11.5M 0.23% 164
2018
Q4
$40.3M Buy
1,146,648
+322,275
+39% +$11.2M 0.34% 102
2018
Q3
$27M Buy
824,373
+98,325
+14% +$3.13M 0.19% 187
2018
Q2
$22.5M Buy
726,048
+574,225
+378% +$16.4M 0.18% 201
2018
Q1
$4.11M Buy
+151,823
New +$4.05M 0.03% 385

Other funds holding OHI

Carillon Tower Advisers's OHI Position: Q1 2020 in Review

Carillon Tower Advisers sold out of Omega Healthcare (OHI) in Q1 2020, closing a stake of 723,248 shares — an estimated $30.6M sold.

Carillon Tower Advisers first reported a position in OHI in Q1 2018 and held it in 8 quarters. The position peaked at $40.3M in Q4 2018. 470 funds tracked by Wall St. Rank hold OHI as of Q1 2020.

  • Carillon Tower Advisers reported no remaining Omega Healthcare position as of Q1 2020 after selling out during the quarter.
  • Carillon Tower Advisers sold 723,248 Omega Healthcare shares in Q1 2020, an estimated $30.6M.
  • Carillon Tower Advisers first reported a position in Omega Healthcare in Q1 2018 and held it in 8 quarters.
  • Carillon Tower Advisers's Omega Healthcare position peaked at $40.3M in Q4 2018.
  • 470 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2020.

Based on Carillon Tower Advisers's 13F filing for Q1 2020, filed 11 May 2020.